|
The future of vaccination
In the future, vaccines will offer some of the biggest improvements
in public health. Traditional vaccines work by teaching the
immune system how to respond to a potential pathogen, using
techniques which are not too different from those used by
Louis Pasteur a hundred years ago.
However, advances in molecular biology mean that scientists
no longer have to inject the entire organism. Instead, they
can thoroughly investigate a pathogenic organism to determine
which of its components create immunity. For example, whooping
cough vaccines have been developed incorporating a small number
of the whooping cough bacterium’s components. This potentially
reduces some of the side-effects associated with using the
entire bacterium as a vaccine.
Expanding technology and an increased understanding of the
infecting organisms and the immune system will allow major
advances in vaccinology. In the future, new approaches such
as inhaled vaccines and injectable DNA vaccines will become
available. In addition, countries with less developed health
systems will benefit from new delivery forms such as ‘edible
vaccines’, genetically engineered into staple foods such as
bananas.
The search is underway for an effective vaccine against human
immunodeficiency virus (HIV), the cause of AIDS, and there
is also the exciting prospect that malaria, one of the world’s
major infectious diseases, may be controlled by vaccination.
Therapeutic vaccines are in development that are designed
to stimulate the immune system to fight existing disease,
rather than preventing a future infection. Three such vaccines
– for type 1 diabetes, multiple sclerosis and rheumatoid arthritis
– are now listed as ‘most favourable’ candidates and are in
development in the USA. Development prospects for an anti-melanoma
vaccine are also encouraging.
Many diseases are known to be partly triggered by infectious
agents which could be treated with vaccines. The US National
Cancer Institute is conducting a large-scale clinical trial
of a new human papilloma virus vaccine as an addition to radiotherapy
or chemotherapy for the treatment of cervical cancer.
In the paediatric arena, new vaccines are being developed
against serious respiratory infections caused by various bacteria
and viruses. Vaccines are also being developed to protect
against E. coli and the salmonella pathogens which cause food
poisoning, the H. pylori bacteria implicated in stomach
cancer and gastric ulcers, and for sexually-transmitted diseases
such as herpes and chlamydia. Prevention of illness through
vaccination means that, one day, these infections may be a
thing of the past.
|